| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 14.149 | 104.385 | 280.361 | 497.626 | 1.280.151 | 1.936.770 | 3.006.161 | 2.988.218 | 3.732.184 |
| Total Income - EUR | - | 14.310 | 110.290 | 297.572 | 499.765 | 1.307.223 | 1.966.328 | 3.090.096 | 3.042.498 | 4.163.239 |
| Total Expenses - EUR | - | 13.275 | 102.319 | 263.373 | 435.489 | 1.111.285 | 1.678.443 | 2.918.384 | 2.831.178 | 3.876.493 |
| Gross Profit/Loss - EUR | - | 1.035 | 7.971 | 34.199 | 64.276 | 195.938 | 287.885 | 171.712 | 211.320 | 286.746 |
| Net Profit/Loss - EUR | - | 608 | 6.700 | 31.224 | 59.278 | 179.808 | 249.242 | 148.524 | 185.731 | 280.569 |
| Employees | - | 1 | 0 | 4 | 3 | 7 | 10 | 17 | 12 | 13 |
Check the financial reports for the company - Cosamira Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 149 | 15.855 | 29.211 | 33.311 | 119.407 | 540.311 | 946.089 | 1.396.970 | 1.295.075 |
| Current Assets | - | 6.687 | 11.912 | 47.737 | 119.865 | 368.776 | 539.630 | 643.550 | 633.850 | 1.057.860 |
| Inventories | - | 2.527 | 6.021 | 18.941 | 32.805 | 128.375 | 235.261 | 438.276 | 411.601 | 554.668 |
| Receivables | - | 1.874 | 2.215 | 5.270 | 37.722 | 178.660 | 265.736 | 178.465 | 198.506 | 409.420 |
| Cash | - | 2.286 | 3.676 | 23.526 | 49.338 | 61.741 | 38.633 | 26.809 | 23.743 | 93.772 |
| Shareholders Funds | - | 652 | 7.341 | 48.101 | 101.601 | 196.789 | 405.239 | 512.965 | 697.140 | 705.222 |
| Social Capital | - | 45 | 44 | 9.713 | 9.525 | 9.344 | 13.140 | 18.331 | 18.276 | 18.173 |
| Debts | - | 6.184 | 20.426 | 28.847 | 51.575 | 291.394 | 674.701 | 1.077.580 | 1.335.889 | 1.649.308 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1722 - 1722" | |||||||||
| CAEN Financial Year |
1722
|
|||||||||
Comments - Cosamira Bio S.r.l.